Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Neuropathologica
Published in: Acta Neuropathologica 4/2012

Open Access 01-10-2012 | Original Paper

Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction

Authors: Jessica L. Teeling, Roxana O. Carare, Martin J. Glennie, V. Hugh Perry

Published in: Acta Neuropathologica | Issue 4/2012

Login to get access

Abstract

In this study, we investigate the underlying mechanisms of antibody-mediated inflammation in the brain. We show that immune complexes formed in the brain parenchyma generate a robust and long-lasting inflammatory response, characterized by increased expression of the microglia markers CD11b, CD68 and FcRII/III, but no neutrophil recruitment. In addition to these histological changes, we observed transient behavioural changes that coincided with the inflammatory response in the brain. The inflammatory and behavioural changes were absent in Fc-gamma chain (Fcγ)-deficient mice, while C1q-deficient mice were not different from wild-type mice. We conclude that, in the presence of antigen, antibodies can lead to a local immune complex-mediated inflammatory reaction in the brain parenchyma and indirectly induce neuronal tissue damage through recruitment and activation of microglia via Fcγ receptors. These observations may have important implications for the development of therapeutic antibodies directed against neuronal antigens used for therapeutic intervention in neurological diseases.
Literature
1.
Alexander EL, Sanders SK (1977) F(ab’)2 reagents are not required if goat, rather than rabbit, antibodies are used to detect human surface immunoglobulin. J Immunol 119(3):1084–1088PubMed
2.
Andersson PB, Perry VH, Gordon S (1992) The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48(1):169–186PubMedCrossRef
3.
Andersson PB, Perry VH, Gordon S (1992) Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 176(1):255–259PubMedCrossRef
4.
Banks WA, Erickson MA (2010) The blood–brain barrier and immune function and dysfunction. Neurobiol Dis 37(1):26–32PubMedCrossRef
5.
Banks WA, Terrell B, Farr SA, Robinson SM, Nonaka N, Morley JE (2002) Passage of amyloid beta protein antibody across the blood–brain barrier in a mouse model of Alzheimer’s disease. Peptides 23(12):2223–2226PubMedCrossRef
6.
Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA (2008) Consequence of Abeta immunization on the vasculature of human Alzheimer’s disease brain. Brain 131(Pt 12):3299–3310PubMedCrossRef
7.
Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19(1):56–59PubMedCrossRef
8.
Carty NC, Wilcock DM, Rosenthal A, Grimm J, Pons J, Ronan V, Gottschall PE, Gordon MN, Morgan D (2006) Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice. J Neuroinflammation 3:11PubMedCrossRef
9.
Chen S, Le WD, Xie WJ, Alexianu ME, Engelhardt JI, Siklos L, Appel SH (1998) Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol 55(8):1075–1080PubMedCrossRef
10.
Crawford JP, Movat HZ, Minta JO, Opas M (1985) Acute inflammation induced by immune complexes in the microcirculation. Exp Mol Pathol 42(2):175–193PubMedCrossRef
11.
D’Andrea MR (2003) Evidence linking neuronal cell death to autoimmunity in Alzheimer’s disease. Brain Res 982(1):19–30PubMedCrossRef
12.
Davidoff LM, Seegal BC, Seegal D (1932) The arthus phenomenon: local anaphylactic inflammation in the rabbit brain. J Exp Med 55(1):163–168PubMedCrossRef
13.
Engelhardt JI, Le WD, Siklos L, Obal I, Boda K, Appel SH (2000) Stereotaxic injection of IgG from patients with Alzheimer disease initiates injury of cholinergic neurons of the basal forebrain. Arch Neurol 57(5):681–686PubMedCrossRef
14.
Fukuchi K, Tahara K, Kim HD, Maxwell JA, Lewis TL, Accavitti-Loper MA, Kim H, Ponnazhagan S, Lalonde R (2006) Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer’s disease. Neurobiol Dis 23(3):502–511PubMedCrossRef
15.
16.
He Y, Le WD, Appel SH (2002) Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Exp Neurol 176(2):322–327PubMedCrossRef
17.
Herber DL, Maloney JL, Roth LM, Freeman MJ, Morgan D, Gordon MN (2006) Diverse microglial responses after intrahippocampal administration of lipopolysaccharide. Glia 53(4):382–391PubMedCrossRef
18.
Hu P, Pollard JD, Chan-Ling T (2000) Breakdown of the blood–retinal barrier induced by activated T cells of nonneural specificity. Am J Pathol 156(4):1139–1149PubMedCrossRef
19.
Hunter RL, Cheng B, Choi DY, Liu M, Liu S, Cass WA, Bing G (2009) Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J Neurosci Res 87(8):1913–1921. doi:10.​1002/​jnr.​22012 PubMedCrossRef
20.
Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131(Pt 11):3072–3080PubMedCrossRef
21.
Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099PubMedCrossRef
22.
Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH (2001) Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson’s disease. J Neurosci 21(21):8447–8455PubMed
23.
Leigh PN, Reavill C, Jenner P, Marsden CD (1983) Basal ganglia outflow pathways and circling behaviour in the rat. J Neural Transm 58(1–2):1–41PubMedCrossRef
24.
Lewis PA (1908) The induced susceptibility of the guinea-pig to the toxic action of the blood serum of the horse. J Exp Med 10(1):1–29PubMedCrossRef
25.
Lister KJ, Hickey MJ (2006) Immune complexes alter cerebral microvessel permeability: roles of complement and leukocyte adhesion. Am J Physiol Heart Circ Physiol 291(2):H694–H704PubMedCrossRef
26.
Loughlin AJ, Woodroofe MN, Cuzner ML (1992) Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: effects on interferon-gamma induced activation. Immunology 75(1):170–175PubMed
27.
Lunnon K, Teeling JL, Tutt AL, Cragg MS, Glennie MJ, Perry VH (2011) Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J Immunol 186(12):7215–7224PubMedCrossRef
28.
Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ (2009) Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun 33(3–4):247–254PubMedCrossRef
29.
Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9(4):448–452PubMedCrossRef
30.
Perry VH, Andersson PB (1992) The inflammatory response in the CNS. Neuropathol Appl Neurobiol 18(5):454–459PubMedCrossRef
31.
Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15(2):313–326PubMedCrossRef
32.
Poduslo JF, Curran GL, Berg CT (1994) Macromolecular permeability across the blood-nerve and blood–brain barriers. Proc Natl Acad Sci USA 91(12):5705–5709PubMedCrossRef
33.
Poduslo JF, Ramakrishnan M, Holasek SS, Ramirez-Alvarado M, Kandimalla KK, Gilles EJ, Curran GL, Wengenack TM (2007) In vivo targeting of antibody fragments to the nervous system for Alzheimer’s disease immunotherapy and molecular imaging of amyloid plaques. J Neurochem 102(2):420–433PubMedCrossRef
34.
Ravetch JV (2002) A full complement of receptors in immune complex diseases. J Clin Invest 110(12):1759–1761PubMed
35.
Ryu E, Fridley BL, Tosakulwong N, Bailey KR, Edwards AO (2010) Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study. Molecular vision 16:2811–2821PubMed
36.
Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133(Pt 2):349–361PubMedCrossRef
37.
Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400(6740):173–177PubMedCrossRef
38.
Schupf N, Williams CA (1987) Complement-dependence of immune complex activity in the rat hypothalamus. Ann N Y Acad Sci 496:399–404PubMedCrossRef
39.
Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE (2002) C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest 110(12):1823–1830PubMed
40.
Sylvestre DL, Ravetch JV (1994) Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265(5175):1095–1098PubMedCrossRef
41.
Szalai AJ, Digerness SB, Agrawal A, Kearney JF, Bucy RP, Niwas S, Kilpatrick JM, Babu YS, Volanakis JE (2000) The Arthus reaction in rodents: species-specific requirement of complement. J Immunol 164(1):463–468PubMed
42.
Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76(3):519–529PubMedCrossRef
43.
Teeling JL, Felton LM, Deacon RM, Cunningham C, Rawlins JN, Perry VH (2007) Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav Immun 21(6):836–850PubMedCrossRef
44.
Westland KW, Pollard JD, Sander S, Bonner JG, Linington C, McLeod JG (1999) Activated non-neural specific T cells open the blood–brain barrier to circulating antibodies. Brain 122(Pt 7):1283–1291PubMedCrossRef
45.
Wilcock DM, Alamed J, Gottschall PE, Grimm J, Rosenthal A, Pons J, Ronan V, Symmonds K, Gordon MN, Morgan D (2006) Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. J Neurosci 26(20):5340–5346PubMedCrossRef
46.
Wilcock DM, Colton CA (2008) Anti-amyloid-beta immunotherapy in Alzheimer’s disease: relevance of transgenic mouse studies to clinical trials. J Alzheimers Dis 15(4):555–569PubMed
47.
Wilcock DM, Colton CA (2009) Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice. CNS Neurol Disord Drug Targets 8(1):50–64PubMedCrossRef
48.
Wilcock DM, Rojiani A, Rosenthal A, Levkowitz G, Subbarao S, Alamed J, Wilson D, Wilson N, Freeman MJ, Gordon MN, Morgan D (2004) Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci 24(27):6144–6151PubMedCrossRef
49.
Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, Morgan D (2004) Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 1(1):24PubMedCrossRef
Metadata
Title
Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction
Authors
Jessica L. Teeling
Roxana O. Carare
Martin J. Glennie
V. Hugh Perry
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 4/2012
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-012-0995-3

Other articles of this Issue 4/2012

Acta Neuropathologica 4/2012 Go to the issue

Original Paper

Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA

Original Paper

Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain

Review

Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden

Original Paper

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

Original Paper

Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats

Original Paper

Multiple routes of invasion of wild-type Clade 1 highly pathogenic avian influenza H5N1 virus into the central nervous system (CNS) after intranasal exposure in ferrets